Neuromuscular Nondepolarizing Agents
"Neuromuscular Nondepolarizing Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants.
Descriptor ID |
D003473
|
MeSH Number(s) |
D27.505.696.663.700.710.575
|
Concept/Terms |
Neuromuscular Nondepolarizing Agents- Neuromuscular Nondepolarizing Agents
- Agents, Neuromuscular Nondepolarizing
- Nondepolarizing Agents, Neuromuscular
- Curariform Drugs
- Drugs, Curariform
- Nondepolarizing Blockers
- Blockers, Nondepolarizing
- Neuromuscular Blocking Agents, Competitive
- Curare-Like Agents
- Agents, Curare-Like
- Curare Like Agents
- Muscle Relaxants, Non-Depolarizing
- Muscle Relaxants, Non Depolarizing
- Non-Depolarizing Muscle Relaxants
|
Below are MeSH descriptors whose meaning is more general than "Neuromuscular Nondepolarizing Agents".
Below are MeSH descriptors whose meaning is more specific than "Neuromuscular Nondepolarizing Agents".
This graph shows the total number of publications written about "Neuromuscular Nondepolarizing Agents" by people in this website by year, and whether "Neuromuscular Nondepolarizing Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1996 | 1 | 0 | 1 |
1997 | 1 | 0 | 1 |
2004 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2012 | 0 | 1 | 1 |
2015 | 1 | 0 | 1 |
2020 | 0 | 1 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neuromuscular Nondepolarizing Agents" by people in Profiles.
-
MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants. Cells. 2021 01 15; 10(1).
-
Effects on Postoperative Gastrointestinal Motility After Neuromuscular Blockade Reversal With Sugammadex Versus Neostigmine/Glycopyrrolate in Colorectal Surgery Patients. Ann Pharmacother. 2020 12; 54(12):1165-1174.
-
Impact of Rocuronium and Succinylcholine on Sedation Initiation After Rapid Sequence Intubation. J Emerg Med. 2015 Jul; 49(1):43-9.
-
Methohexital and succinylcholine dosing for electroconvulsive therapy (ECT): actual versus ideal. J ECT. 2012 Sep; 28(3):e29-30.
-
The effect of neuromuscular blockade on mask ventilation. Anaesthesia. 2011 Mar; 66(3):163-7.
-
Anesthetic management of a patient with asystolic spells. J Clin Anesth. 2004 May; 16(3):207-9.
-
Nondepolarizing neuromuscular blocking drugs in the intensive care unit: a clinical review. South Med J. 1997 Aug; 90(8):769-74.
-
The effect of muscle relaxants on cricothyroid muscle: a report of three cases. Anesth Analg. 1996 Mar; 82(3):657-60.
-
Pain on injection of rocuronium bromide. Anesth Analg. 1995 May; 80(5):1067.
-
Mivacurium infusion during nitrous oxide-isoflurane anesthesia: a comparison with nitrous oxide-opioid anesthesia. J Clin Anesth. 1992 Mar-Apr; 4(2):123-6.